Skip to main content

Rider Michael J

In the past year, 4 open-market sale filings worth $64.7K and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$64.7K
4 filings
Net
−$64.7K
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Rider Michael J as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Feb 6, 2026 (view filing)Feb 42 daysRider Michael JGlobal General CounselSSaleResMed Common Stock−50$260.00−$13.0K−0.5%9.69K after10b5-1
Jan 5, 2026 (view filing)Jan 23 daysRider Michael JGlobal General CounselSSaleResMed Common Stock−50$241.75−$12.1K−0.5%9.74K after10b5-1
Dec 2, 2025 (view filing)Dec 11 dayRider Michael JGlobal General CounselSSaleResMed Common Stock−50$244.16−$12.2K−0.5%9.79K after10b5-1
Oct 2, 2025 (view filing)Oct 11 dayRider Michael JGlobal General CounselSSaleResMed Common Stock−100$274.36−$27.4K−0.9%11.3K after10b5-1
Aug 4, 2025 (view filing)Aug 13 daysRider Michael JGlobal General CounselSSaleResMed Common Stock−50$281.90−$14.1K−0.6%8.49K after10b5-1
Jul 2, 2025 (view filing)Jul 11 dayRider Michael JGlobal General CounselSSaleResMed Common Stock−66$256.99−$17.0K−0.8%8.54K after10b5-1
Jun 3, 2025 (view filing)Jun 21 dayRider Michael JGlobal General CounselSSaleResMed Common Stock−41$243.78−$9.99K−0.5%8.87K after10b5-1
Apr 3, 2025 (view filing)Apr 12 daysRider Michael JGlobal General CounselSSaleResMed Common Stock−64$222.86−$14.3K−0.7%8.85K after10b5-1
Mar 4, 2025 (view filing)Mar 31 dayRider Michael JGlobal General CounselSSaleResMed Common Stock−64$234.10−$15.0K−0.7%8.91K after10b5-1
Feb 4, 2025 (view filing)Feb 31 dayRider Michael JGlobal General CounselSSaleResMed Common Stock−64$242.42−$15.5K−0.7%8.97K after10b5-1
Jan 3, 2025 (view filing)Jan 21 dayRider Michael JGlobal General CounselSSaleResMed Common Stock−75$230.99−$17.3K−0.8%9.04K after10b5-1
Dec 2, 2024 (view filing)Dec 2Same dayRider Michael JGlobal General CounselSSaleResMed Common Stock−74$248.91−$18.4K−0.8%9.11K after10b5-1
Nov 5, 2024 (view filing)Nov 14 daysRider Michael JGlobal General CounselSSaleResMed Common Stock−69$242.00−$16.7K−0.7%10.4K after10b5-1
Aug 21, 2024 (view filing)Aug 201 dayRider Michael JGlobal General CounselSSaleResMed Common Stock−882$231.00−$203.7K−7.7%10.5K after10b5-1
Mar 6, 2024 (view filing)Mar 42 daysRider Michael JGlobal General CounselSSaleResMed Common Stock−81$180.00−$14.6K−1.2%6.61K after10b5-1
Mar 4, 2024 (view filing)Mar 13 daysRider Michael JGlobal General CounselSSaleResMed Common Stock−200$173.25−$34.6K−2.9%6.69K after10b5-1
Nov 2, 2023 (view filing)Nov 11 dayRider Michael JGlobal General CounselSSaleResMed Common Stock−25$143.42−$3.59K−0.3%7.36K after10b5-1
Oct 4, 2023 (view filing)Oct 22 daysRider Michael JGlobal General CounselSSaleResMed Common Stock−25$145.92−$3.65K−0.3%7.38K after10b5-1
Sep 7, 2023 (view filing)Sep 16 daysLateRider Michael JGlobal General CounselSSaleResMed Common Stock−25$161.15−$4.03K−0.3%7.41K after10b5-1
Aug 2, 2023 (view filing)Aug 11 dayRider Michael JGlobal General CounselSSaleResMed Common Stock−25$224.12−$5.60K−0.5%5.19K after10b5-1
Jul 5, 2023 (view filing)Jul 32 daysRider Michael JGlobal General CounselSSaleResMed Common Stock−25$217.21−$5.43K−0.5%5.21K after10b5-1